Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The Merck Druggernaut
An in-depth look at big pharma's flagship company The Merck Druggernaut takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmace...
Nachhaltigkeit im unternehmerischen Diskurs
Wie interpretierten Unternehmen das Leitbild der Nachhaltigkeit? Wie setzten sie es in die Praxis um? Karen Froitzheim untersucht die vielfältigen Praktiken der Nachhaltigkeit, die vier Unternehmen der Handels- und der Konsumgüter- sowie der Chemie- und der Pharmabranche in Deutschland und Großbritannien (Merck, AstraZenca, Otto und Marks & Spencer) zwischen 1987 und 2010 etablierten. Auf breiter Quellenbasis arbeitet sie die Wechselwirkungen zwischen Politik, Gesellschaft und Wirtschaft heraus und analysiert Ursprünge und Herausforderungen unternehmerischer Nachhaltigkeit. So kann sie zeigen, dass die Konzerne im Spannungsfeld von Politik und Wettbewerb den »grünen Konsumenten« erst schaffen mussten und Nachhaltigkeit zunehmend als Business Case unter Berücksichtigung ökonomischer, ökologischer und sozialer Aspekte kommunizierten.
X-ray Contrast Agent Technology
This book documents the fascinating history of radiological techniques that use contrast agents. The text includes many of the fundamental documentary sources that bring to life the social and scientific background of the discoveries, the personalities of the discoverers, and implementation of new technologies. Such agents when used with X-rays allow clinicians to distinguish anatomical structures with nearly identical densities. Focus is on urological and angiographic uses of contrast agents. Key selling features: Documents and thoroughly references the history of contrast agent development Reviews the priority and importance of patents Discusses the role that important individual scientists and leading research institutions have played in technology development and implementation
News
None
Merck
Merck is the oldest pharmaceutical-chemical company in the world. It developed into a global corporation from a Darmstadt pharmacy that Jacob Friedrich Merck received the pharmacist’s license for in 1668. This book tells the 350-year history of the company for the first time in its entirety and on the basis of all the available sources, as well as the newest research in business history. For a long time, family-owned companies were regarded as a dying breed. The future seemed to belong to jointstock companies with an anonymous stockholder structure. Yet there are numerous successful counterexamples in Germany, such as Bosch, C&A and Bertelsmann. Merck, too, counts among them. How did the Merck family manage to keep the company in its possession for 13 generations through all the political ruptures and historical crises and turn it into a global leader among science and technology firms? With this as their central question, four acclaimed historians recount the fascinating history of the Merck company between 1668 and 2018, embedding it in the eventful course of world history.
Le démon moderne
None
Order and Disorder
The papers in this volume set the background against which the food crises of the 19th and 20th centuries can be judged. The papers presented by guest speaker Professor Hugh Pennington, Head of the University of Aberdeen's Department of Medical Microbiology, looks at the harsh realities of facing us at the beginning of the new millennium.
Neue Forschungen zur Medizingeschichte
Der vierte Band der Schriften des Rheinischen Kreises der Medizinhistoriker setzt die eingeführte Reihe fort und bietet Arbeiten zu fünf Themenschwerpunkten: Antike und Mittelalter, Nationalsozialismus und Nachkriegszeit, Entwicklungszusammenarbeit und Global Health, Medizinhistorische Biographien und Pharmaziegeschichte. Die Mehrzahl der Beiträge verdankt sich den Jahrestagungen des Rheinischen Kreises in Bonn 2013 und auf Schloss Burg an der Wupper 2014. Neben Historikern kommen praktische Ärzte und Apotheker zu Wort, darüber hinaus Studierende und Doktoranden aus den Universitäts-Instituten des Rheinlandes und angrenzender Regionen.
